Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10059007HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10059334HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10058999HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10062375HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10059332HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10059333HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10060331HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10058997HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10059005HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10059331HBVENSG00000163631.19protein_codingALBNoNo213P02768
TCGA Plot Options
Drug Information
GeneALB
DrugBank IDDB06713
Drug NameNorelgestromin
Target IDBE0000530
UniProt IDP02768
Regulation Type
PubMed IDs12586319
CitationsHammond GL, Abrams LS, Creasy GW, Natarajan J, Allen JG, Siiteri PK: Serum distribution of the major metabolites of norgestimate in relation to its pharmacological properties. Contraception. 2003 Feb;67(2):93-9.
GroupsApproved; Investigational
Direct ClassificationEstrane steroids
SMILES[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(C=C3CC[C@@]21[H])=NO
Pathways
PharmGKB
ChEMBLCHEMBL1200807